About Us

Development History


2023

2023, certified by FSSC 22000

2022

In 2022, the company received its 15th granted patent

2021

In 2021, a semi-automatic production line of phosphatidylserine (PS) phospholipid, a new food raw material with an annual output of 100 tons of medicinal egg yolk lecithin, will be built.

2019

2019, Halal Certified

2018

In 2018, the company's "substitution of imported high-end phospholipid industrialization project" was listed by the National Development and Reform Commission as a "three-year action plan investment project for emerging industries within the central budget"; the company was awarded a small giant enterprise.

2017

In 2017, he obtained the national high-tech enterprise certificate; the "high-end phospholipid series product technology development and industrialization research project" was 10 million invested by the provincial government.

2016

In 2016, it obtained the 23 million investment of Shenyang Municipal Government Biomedical Venture Capital Company; obtained the "Food Production License"; in the same year, it passed the ISO9001 International Quality System Certification and Kosher Food Certification.

2013

In April 2013, soybean phospholipid was approved by Liaoning Food and Drug Administration and obtained the registration approval of pharmaceutical excipients, and the company entered the pharmaceutical excipients industry. In the same year, he won the first prize of municipal scientific and technological achievements and the second prize of provincial scientific and technological achievements;

2012

In 2012, a pharmaceutical soybean phospholipid production line was built

2010

In May 2010, it obtained the "drug production license", marking the company's official entry into the pharmaceutical field.

2009

In 2009, it was granted a patent.

2008

In June 2008, the experiment of soybean phospholipid R & D project was started.

2005

In 2005, Shenyang Tianfeng Biopharmaceutical Co., Ltd. was established.